Skip to main content
Clinical Trials/NCT06408493
NCT06408493
Completed
N/A

Peer-led Digital Health Lifestyle Intervention for a Low Income Community at Risk for Cardiovascular Diseases (MYCardio-PEER)

Monash University Malaysia1 site in 1 country63 target enrollmentMarch 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Primary Prevention of Cardiovascular Diseases
Sponsor
Monash University Malaysia
Enrollment
63
Locations
1
Primary Endpoint
Framingham Risk Score for Cardiovascular Disease Risk
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The goal of this interventional study is to develop and assess the effectiveness of a peer-led digital health program (MYCardio-PEER) for primary prevention of cardiovascular disease (CVD) in a low-income community at-risk of CVD.

The main questions it aims to answer are:

  • Is MYCardio-PEER effective in improving knowledge, lifestyle behaviors and CVD biomarkers of a low-income community at-risk for CVD?
  • Is there an association between MYCardio-PEER participants' adherence and satisfaction, with effectiveness and sustainability of the program?

Participants will attend the 8-weeks MYCardio-PEER program with their peer leaders, supplemented with face-to-face components. Participants will then be followed up for another 12 weeks, during which peer leaders and researchers will have minimal contact with the participants. Participants who have been allocated into the control group will receive printed documents with standard tips on dietary and lifestyle management for CVD, where they will be encouraged to maintain regular calorie intake and expenditure and perform regular exercise.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
December 31, 2024
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Monash University Malaysia
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Mentally sound man/woman of at least 30 years old
  • Monthly household income of less than RM3,710 or receiving government aid for low-income community
  • Literate with a fair command of the Malay language
  • Have mobile device connected to the Internet
  • Willing to attend 8 weeks of intervention and be followed up for another 12 weeks during the maintenance phase.
  • Have been confirmed to have a moderate or high risk for CVD based on the Framingham General CVD Risk Score

Exclusion Criteria

  • Pregnant, lactating or intend to become pregnant during the study period.
  • Any other pre-existing conditions or severe complications that could compromise the ability to adhere to the study program.
  • Enrolled in other studies.

Outcomes

Primary Outcomes

Framingham Risk Score for Cardiovascular Disease Risk

Time Frame: 20 weeks

The score is based on a person's age, sex, blood pressure, cholesterol levels, smoking status, and diabetes status. The calculated score will be converted into 10-year risk percentage whereby the higher the percentage means higher cardiovascular disease risk.

Secondary Outcomes

  • Body weight(20 weeks)
  • Low-density lipoprotein cholesterol (LDL-C) level(20 weeks)
  • High-density lipoprotein cholesterol (HDL-C) level(20 weeks)
  • Blood pressure(20 weeks)
  • Triglycerides level(20 weeks)
  • Fasting blood glucose level(20 weeks)
  • Total cholesterol level(20 weeks)
  • Body height(Baseline)
  • Attitude and Beliefs about Cardiovascular Risk(20 weeks)
  • Dietary intakes(20 weeks)
  • Waist circumference(20 weeks)
  • Nutrient intakes(20 weeks)
  • Smoking habit(20 weeks)
  • Body mass index(20 weeks)
  • Medication Understanding and Taking Self-Efficacy(20 weeks)
  • Alcohol consumption(20 weeks)
  • Physical activity level(20 weeks)
  • Stress level(20 weeks)

Study Sites (1)

Loading locations...

Similar Trials